PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32621159 ↗2020Reported benefit

Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.

RatTBIUnspecifiedWistarMalen = Male Wistar rats divided into eight groups; numbers per gro…100 and 200 mg/kg

Model: Acute severe traumatic brain injury in rats

Metformin at 100 and 200 mg/kg attenuated brain oedema and blood-brain barrier disruption and improved vestibulomotor function with an increased p-AMPK/AMPK ratio, and these effects were abolished by the AMPK inhibitor compound C.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.